FilingReader Intelligence
BrightGene raises 500m yuan from controlling shareholder
July 18, 2025 at 11:19 AM UTC•By FilingReader AI
BrightGene Bio-Medical Technology will raise up to 500 million yuan through a private placement of A-shares to controlling shareholder Yuan Jiandong.
The funds will be used to boost liquidity and repay bank loans. The subscribed shares will have a 48-month lock-up period.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement on the dilution of immediate returns and compensatory measures, and undertakings by relevant parties, regarding the 2024 private placement of A-shares (second revision draft)July 18, 2025 at 08:00 AM UTC
Announcement on the supplementary agreement to the share subscription agreement with conditions precedent signed with specific parties and on related party transactionsJuly 18, 2025 at 08:00 AM UTC
Announcement on the revised proposal for the 2024 non-public offering of A-shares to specific objectsJuly 18, 2025 at 08:00 AM UTC
Announcement regarding penalties or regulatory measures imposed by securities regulatory authorities and exchanges over the past five years (second revised draft)July 18, 2025 at 08:00 AM UTC
2024 proposal for a private placement of A-shares (second revised draft)July 18, 2025 at 08:00 AM UTC
Argumentation and analysis report on the plan for the 2024 non-public offering of A-shares to specific objects (second revised draft)July 18, 2025 at 08:00 AM UTC
Announcement regarding Yuan Jiandong's commitment letter concerning the company's 2024 private placement of sharesJuly 18, 2025 at 08:00 AM UTC
Minsheng Securities Company Limited's supplementary agreement regarding Borui Bio-Pharmaceutical (Suzhou) Company Limited's conditional share subscription agreement signed with specific subscribers, and verification opinion on the related party transactionJuly 18, 2025 at 08:00 AM UTC
Indicative announcement regarding the disclosure of the second revised draft of the proposal for the 2024 non-public issuance of A-shares to specific subscribersJuly 18, 2025 at 08:00 AM UTC
SSE:688166•Shanghai Stock Exchange
News Alerts
Get instant email alerts when BrightGene Bio-Medical Technology publishes news
Free account required • Unsubscribe anytime